Logo image of CLNE

CLEAN ENERGY FUELS CORP (CLNE) Stock Fundamental Analysis

USA - NASDAQ:CLNE - US1844991018 - Common Stock

2.6 USD
+0.18 (+7.44%)
Last: 9/16/2025, 8:07:15 PM
2.5999 USD
0 (0%)
After Hours: 9/16/2025, 8:07:15 PM
Fundamental Rating

4

Overall CLNE gets a fundamental rating of 4 out of 10. We evaluated CLNE against 210 industry peers in the Oil, Gas & Consumable Fuels industry. While CLNE seems to be doing ok healthwise, there are quite some concerns on its profitability. CLNE is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CLNE was profitable.
CLNE had a positive operating cash flow in the past year.
CLNE had negative earnings in each of the past 5 years.
CLNE had a positive operating cash flow in each of the past 5 years.
CLNE Yearly Net Income VS EBIT VS OCF VS FCFCLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

CLNE's Return On Assets of -18.24% is on the low side compared to the rest of the industry. CLNE is outperformed by 89.52% of its industry peers.
Looking at the Return On Equity, with a value of -34.45%, CLNE is doing worse than 82.86% of the companies in the same industry.
Industry RankSector Rank
ROA -18.24%
ROE -34.45%
ROIC N/A
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
CLNE Yearly ROA, ROE, ROICCLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

With a Gross Margin value of 29.04%, CLNE perfoms like the industry average, outperforming 40.95% of the companies in the same industry.
In the last couple of years the Gross Margin of CLNE has declined.
CLNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
CLNE Yearly Profit, Operating, Gross MarginsCLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

5

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLNE remains at a similar level compared to 1 year ago.
CLNE has more shares outstanding than it did 5 years ago.
CLNE has a worse debt/assets ratio than last year.
CLNE Yearly Shares OutstandingCLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLNE Yearly Total Debt VS Total AssetsCLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

CLNE has an Altman-Z score of -0.45. This is a bad value and indicates that CLNE is not financially healthy and even has some risk of bankruptcy.
CLNE's Altman-Z score of -0.45 is on the low side compared to the rest of the industry. CLNE is outperformed by 70.48% of its industry peers.
CLNE has a debt to FCF ratio of 10.92. This is a negative value and a sign of low solvency as CLNE would need 10.92 years to pay back of all of its debts.
With a Debt to FCF ratio value of 10.92, CLNE perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
A Debt/Equity ratio of 0.47 indicates that CLNE is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.47, CLNE is in line with its industry, outperforming 50.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 10.92
Altman-Z -0.45
ROIC/WACCN/A
WACC9.41%
CLNE Yearly LT Debt VS Equity VS FCFCLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.83 indicates that CLNE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.83, CLNE belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
A Quick Ratio of 2.51 indicates that CLNE has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.51, CLNE belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.51
CLNE Yearly Current Assets VS Current LiabilitesCLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 400.00% over the past year.
Measured over the past years, CLNE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.00% on average per year.
CLNE shows a small growth in Revenue. In the last year, the Revenue has grown by 4.07%.
The Revenue has been growing slightly by 3.86% on average over the past years.
EPS 1Y (TTM)400%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%-100%
Revenue 1Y (TTM)4.07%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%4.76%

3.2 Future

CLNE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.66% yearly.
The Revenue is expected to grow by 21.81% on average over the next years. This is a very strong growth
EPS Next Y-329.5%
EPS Next 2Y-86.75%
EPS Next 3Y-36.59%
EPS Next 5Y43.66%
Revenue Next Year1.75%
Revenue Next 2Y2.1%
Revenue Next 3Y5.16%
Revenue Next 5Y21.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLNE Yearly Revenue VS EstimatesCLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
CLNE Yearly EPS VS EstimatesCLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 52.00 indicates a quite expensive valuation of CLNE.
CLNE's Price/Earnings ratio is a bit more expensive when compared to the industry. CLNE is more expensive than 64.76% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, CLNE is valued quite expensively.
The Forward Price/Earnings Ratio is negative for CLNE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 52
Fwd PE N/A
CLNE Price Earnings VS Forward Price EarningsCLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

71.90% of the companies in the same industry are cheaper than CLNE, based on the Enterprise Value to EBITDA ratio.
CLNE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 22.18
EV/EBITDA 46.34
CLNE Per share dataCLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

CLNE's earnings are expected to decrease with -36.59% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-86.75%
EPS Next 3Y-36.59%

More info and screens

0

5. Dividend

5.1 Amount

CLNE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (9/16/2025, 8:07:15 PM)

After market: 2.5999 0 (0%)

2.6

+0.18 (+7.44%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners48.97%
Inst Owner Change-6.37%
Ins Owners1.14%
Ins Owner Change-0.29%
Market Cap570.15M
Analysts81.33
Price Target4.58 (76.15%)
Short Float %4.91%
Short Ratio4.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103%
Min EPS beat(2)100%
Max EPS beat(2)106%
EPS beat(4)4
Avg EPS beat(4)143.96%
Min EPS beat(4)100%
Max EPS beat(4)185.77%
EPS beat(8)8
Avg EPS beat(8)152.93%
EPS beat(12)11
Avg EPS beat(12)112.95%
EPS beat(16)12
Avg EPS beat(16)74.75%
Revenue beat(2)2
Avg Revenue beat(2)2.05%
Min Revenue beat(2)0.28%
Max Revenue beat(2)3.83%
Revenue beat(4)4
Avg Revenue beat(4)2.69%
Min Revenue beat(4)0.28%
Max Revenue beat(4)4.45%
Revenue beat(8)5
Avg Revenue beat(8)-1.01%
Revenue beat(12)7
Avg Revenue beat(12)0.27%
Revenue beat(16)8
Avg Revenue beat(16)-1.03%
PT rev (1m)5.89%
PT rev (3m)5.89%
EPS NQ rev (1m)6.67%
EPS NQ rev (3m)19.34%
EPS NY rev (1m)50.55%
EPS NY rev (3m)62.68%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-2.33%
Revenue NY rev (1m)-0.99%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE 52
Fwd PE N/A
P/S 1.36
P/FCF 22.18
P/OCF 5.56
P/B 0.97
P/tB 0.97
EV/EBITDA 46.34
EPS(TTM)0.05
EY1.92%
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.12
FCFY4.51%
OCF(TTM)0.47
OCFY17.99%
SpS1.92
BVpS2.69
TBVpS2.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.24%
ROE -34.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.04%
FCFM 6.11%
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 10.92
Debt/EBITDA 28.05
Cap/Depr 81.3%
Cap/Sales 18.27%
Interest Coverage N/A
Cash Conversion 1028.62%
Profit Quality N/A
Current Ratio 2.83
Quick Ratio 2.51
Altman-Z -0.45
F-Score5
WACC9.41%
ROIC/WACCN/A
Cap/Depr(3y)180.71%
Cap/Depr(5y)126.79%
Cap/Sales(3y)20.16%
Cap/Sales(5y)15.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%-100%
EPS Next Y-329.5%
EPS Next 2Y-86.75%
EPS Next 3Y-36.59%
EPS Next 5Y43.66%
Revenue 1Y (TTM)4.07%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%4.76%
Revenue Next Year1.75%
Revenue Next 2Y2.1%
Revenue Next 3Y5.16%
Revenue Next 5Y21.81%
EBIT growth 1Y-97.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year236.53%
EBIT Next 3Y64.03%
EBIT Next 5Y48.15%
FCF growth 1Y141.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y272.51%
OCF growth 3Y16.07%
OCF growth 5Y39.37%